4/12
08:14 am
prax
Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting [Yahoo! Finance]
Low
Report
Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting [Yahoo! Finance]
4/12
08:00 am
prax
Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting
Low
Report
Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting
4/11
01:34 pm
prax
Praxis Precision Medicines (PRAX) Upgraded to Buy: Here's Why [Yahoo! Finance]
Medium
Report
Praxis Precision Medicines (PRAX) Upgraded to Buy: Here's Why [Yahoo! Finance]
4/5
09:09 am
prax
Praxis Precision Medicines to Participate in Upcoming April Conferences [Yahoo! Finance]
Medium
Report
Praxis Precision Medicines to Participate in Upcoming April Conferences [Yahoo! Finance]
4/5
09:00 am
prax
Praxis Precision Medicines to Participate in Upcoming April Conferences
Medium
Report
Praxis Precision Medicines to Participate in Upcoming April Conferences
4/2
05:00 pm
prax
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/28
10:34 am
prax
Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates [Yahoo! Finance]
Low
Report
Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates [Yahoo! Finance]
3/28
12:20 am
prax
Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering
Medium
Report
Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering
3/27
04:01 pm
prax
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
Medium
Report
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
3/27
12:16 pm
prax
Praxis (PRAX) Surges on Positive Epilepsy Study Results [Yahoo! Finance]
Low
Report
Praxis (PRAX) Surges on Positive Epilepsy Study Results [Yahoo! Finance]
3/26
01:56 pm
prax
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its price target raised by analysts at Jefferies Financial Group Inc. from $75.00 to $128.00. They now have a "buy" rating on the stock.
Medium
Report
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its price target raised by analysts at Jefferies Financial Group Inc. from $75.00 to $128.00. They now have a "buy" rating on the stock.
3/26
01:46 pm
prax
Praxis: 2nd Half 2024 ET Readout Could Lead To U.S. Regulatory Filing [Seeking Alpha]
Medium
Report
Praxis: 2nd Half 2024 ET Readout Could Lead To U.S. Regulatory Filing [Seeking Alpha]
3/26
12:26 pm
prax
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.
Medium
Report
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.
3/26
08:58 am
prax
Praxis gains after mid-stage data for epilepsy candidate [Seeking Alpha]
Low
Report
Praxis gains after mid-stage data for epilepsy candidate [Seeking Alpha]
3/26
06:44 am
prax
Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients [Yahoo! Finance]
High
Report
Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients [Yahoo! Finance]
3/26
06:30 am
prax
Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients
High
Report
Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients
3/25
04:06 pm
prax
Praxis Precision Medicines to Host PRAX-628 Program Update [Yahoo! Finance]
High
Report
Praxis Precision Medicines to Host PRAX-628 Program Update [Yahoo! Finance]
3/25
04:01 pm
prax
Praxis Precision Medicines to Host PRAX-628 Program Update
High
Report
Praxis Precision Medicines to Host PRAX-628 Program Update
3/25
06:36 am
prax
A Look At The Intrinsic Value Of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) [Yahoo! Finance]
Medium
Report
A Look At The Intrinsic Value Of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) [Yahoo! Finance]
3/8
02:11 pm
prax
What Makes Praxis Precision Medicines, Inc. (PRAX) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
Low
Report
What Makes Praxis Precision Medicines, Inc. (PRAX) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
3/7
01:39 pm
prax
Praxis Precision Medicines Inc (PRAX) Reports Full-Year 2023 Financial Results and Corporate Updates [Yahoo! Finance]
Low
Report
Praxis Precision Medicines Inc (PRAX) Reports Full-Year 2023 Financial Results and Corporate Updates [Yahoo! Finance]
3/6
08:10 am
prax
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.
Medium
Report
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.
3/5
07:11 am
prax
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]
Low
Report
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]
3/5
07:00 am
prax
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
Low
Report
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
3/1
08:19 am
prax
Praxis Precision Medicines to Participate in TD Cowen's 44th Annual Health Care Conference [Yahoo! Finance]
Medium
Report
Praxis Precision Medicines to Participate in TD Cowen's 44th Annual Health Care Conference [Yahoo! Finance]